Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1106-1116

  Hennessey, Derek ^a,b   Martin, Lynn M ^a   Atzberger, Anne ^a   Lynch, Thomas H ^a,b   Hollywood, Donal ^a   Marignol, Laure ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

HIF 1; Hypoxia; Prostate cancer; Radiation; Resistance

Indexed keywords

COBALT CHLORIDE; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOSENSITIVITY; SENESCENCE; WESTERN BLOTTING;

HIF-1; HYPOXIA; PROSTATE CANCER; RADIATION; RESISTANCE;

APOPTOSIS; BLOTTING, WESTERN; CELL AGING; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884672514     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.10.008     Document Type: Article

References (28)

1. Movsas B., Chapman J.D., Horwitz E.M., et al. Hypoxic regions exist in human prostate carcinoma. Urology 1999, 53:11-18.
2. Krohn K.A., Link J.M., Mason R.P. Molecular imaging of hypoxia. J Nucl Med 2008, 49(Suppl 2):129S-148S.
3. Le Q.T., Courter D. Clinical biomarkers for hypoxia targeting. Cancer Metast Rev 2008, 27:351-362.
4. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955, 9:539-549.
5. Koritzinsky M., Magagnin M.G., van den Beucken T., et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 2006, 25:1114-1125.
6. Dery M.A., Michaud M.D., Richard D.E. Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005, 37:535-540.
7. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732.
8. Quintero M., Mackenzie N., Brennan P.A. Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol 2004, 30:465-468.
9. Aebersold D.M., Burri P., Beer K.T., et al. Expression of hypoxia-inducible factor-1&;α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001, 61:2911-2916.
10. Moeller B.J., Dewhirst M.W. Raising the bar: How HIF-1 helps determine tumor radiosensitivity. Cell Cycle 2004, 3:1107-1110.
11. Hammond E.M., Giaccia A.J. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amst) 2004, 3:1117-1122.
12. Chan N., Koritzinsky M., Zhao H., et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 2008, 68:605-614.
13. Meng A.X., Jalali F., Cuddihy A., et al. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol 2005, 76:168-176.
14. Sprong D., Janssen H.L., Vens C., et al. Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status. Int J Radiat Oncol Biol Phys 2006, 64:562-572.
15. Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 2003, 57:391-401.
16. Kanaya K., Kamitani T. pVHL-independent ubiquitination of HIF1alpha and its stabilization by cobalt ion. Biochem Biophys Res Commun 2003, 306:750-755.
17. Moeller B.J., Richardson R.A., Dewhirst M.W. Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007, 26:241-248.
18. Foley R., Marignol L., Thomas A.Z., et al. The HIF-1&;α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 2009, 8:118-124.
19. Moeller B.J., Cao Y., Li C.Y., et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
20. Gibson S.L., Bindra R.S., Glazer P.M. Hypoxia-induced phosphorylation of Chk2 in an Ataxia telangectasia mutated-dependent manner. Cancer Res 2005, 65:10734-10741.
21. Freiberg R.A., Hammond E.M., Dorie M.J., et al. DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response. Mol Cell Biol 2006, 26:1598-1609.
22. Meyn R.E., Milas L., Ang K.K. The role of apoptosis in radiation oncology. Int J Radiat Biol 2009, 85:107-115.
23. Endlich B., Radford I.R., Forrester H.B., et al. Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat Res 2000, 153:36-48.
24. An W.G., Kanekal M., Simon M.C., et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998, 392:405-408.
25. Chen D., Li M., Luo J., et al. Direct interactions between HIF-1&;α and Mdm2 modulate p53 function. J Biol Chem 2003, 278:13595-13598.
26. Hansson L.O., Friedler A., Freund S., et al. Two sequence motifs from HIF-1&;α bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A 2002, 99:10305-10309.
27. Sullivan R., Pare G.C., Frederiksen L.J., et al. Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol Cancer Ther 2008, 7:1961-1973.
28. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002, 64:993-998.